Results · Apr-Jun 2026 · filed 14 Aug 2026
Gujarat Kidney and Super Speciality Q1 FY27 results
Sales grew 125% to ₹34.3 crore from ₹15.3 crore in Apr-Jun 2025.
Operating profit was ₹8.4 crore, an operating margin of 24.4%.
Net profit was ₹5.3 crore.
Against Jan-Mar 2026: sales +12%, net profit +10%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 34.3 | 15.3 | +125% |
| Operating profit (EBITDA) | 8.4 | - | - |
| Operating margin | 24.4% | - | - |
| Net profit | 5.3 | - | - |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 5 quarters
Filings that week
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 14 Aug 2026Statement Of Deviation & Variation As On June 30, 2026
- 14 Aug 2026Financial Results For Quarter Ended June 2026
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 14 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.